Revive Therapeutics Proposes Private Placement to Raise $1 Million

Revive Therapeutics Ltd., a Toronto-based life sciences company, is planning a private placement of up to 31,250,000 units, priced at $0.032 each. This initiative aims to raise approximately $1,000,000 in gross proceeds. Each unit will include one common share and one purchase warrant, allowing the holder to acquire an additional share for $0.05 within 36 months of closing.

The private placement may occur in tranches and the closing is contingent upon customary conditions. The raised capital is intended for working capital purposes. A hold period of four months plus a day will apply to all securities issued. Finders facilitating the placement will receive 8% of the gross proceeds and broker warrants with similar exercise conditions.